Stuart A. Arbuckle - 06 Dec 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
06 Dec 2022
Net transactions value
$0
Form type
4
Filing time
08 Dec 2022, 15:08:41 UTC
Previous filing
17 Aug 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Award $0 +12,753 +28% $0.000000 58,031 06 Dec 2022 Direct F1
holding VRTX Common Stock 140 06 Dec 2022 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit award that vests on 07/01/2025.